PBMs do not have to be this way.
The company that prices your employees’ prescriptions is paid out of what’s hidden inside that price. Kanurra is a pharmacy benefit manager that earns one flat fee whether your drugs are cheap or expensive, so we have no reason to keep you in the dark.
Thirty minutes with your own claims. Dollars, not percentages. No cost, nothing to sign. Built for self-funded and level-funded plans.
Semaglutide
0.5mg · 1 pen · 28-dayBrand
Under your current PBM
On Kanurra
$935.00 acquisition at invoice, $10.00 dispensing fee, $460.00 rebate returned.
Comparator: Ozempic WAC, Oregon PDAB 2024.
Semaglutide
0.5mg · 1 pen · 28-dayBrand
Under your current PBM
On Kanurra
$935.00 acquisition at invoice, $10.00 dispensing fee, $460.00 rebate returned.
Comparator: Ozempic WAC, Oregon PDAB 2024.
Representative claims. Generic acquisition at CMS NADAC, 12/2025, plus a contracted dispensing fee. Ozempic WAC and commercial rebate, Oregon PDAB 2023/24. Legacy comparator: typical spread contract.
One number on the invoice. Two profits inside.
Most PBMs are paid out of the gap between what they bill you and what they pay the pharmacy, plus the manufacturer rebates they keep.
Billed to your plan
$969.00
Ozempic (semaglutide) 0.5mg1 pen · 28-day supply · one invoice line from a legacy PBM
Paid to the pharmacyKept by the PBM
Kept segment widened to stay visible; not to scale.
- Paid to the pharmacy
- $945.00
- Kept by the PBM
- + $24.00
- Billed to your plan
- $969.00
Separately, from the manufacturer
Drawn against the same $969.00 bill.
- Rebate on this fill, kept by the PBM
- $460.00
Representative claim under a spread contract. What a legacy PBM keeps varies by deal and by drug. What we keep never varies: nothing.
$484.00 of this claim never reached a pharmacy or your plan.
Your old PBM made money twice. We make money once.
Spread
the gap between the bill and the pharmacy's price
A legacy PBM is paid on the gap between its bill and the pharmacy's price.
spread or markup from us, on any claim, ever
Manufacturer rebate
paid by the drug maker on brand fills
A legacy PBM keeps the manufacturer rebate, in part or in whole.
of every rebate dollar we receive, credited to your plan on the claim it came from
Fee
what you pay the PBM to run the benefit
A legacy PBM earns more as your drug costs rise, and often adds implementation, per-claim, prior authorization, platform and data fees on top of the one it quoted.
flat, per employee per month, quoted before you sign. No implementation fee, no per-claim or prior authorization fee, no platform or data fee. It never moves with your drug spend
A ledger you can check.
Pick any line in the ledger above and this is the document that opens: acquisition cost, dispensing fee, the rebate credited back, and where the comparator came from.
- Claim
- CLM-1306
- Filled
- 09:15:19
- Drug
- Semaglutide 0.5mg · 1 pen · 28-day
- Comparator
- Ozempic WAC, Oregon PDAB 2024
- Source
- Representative claims. Generic acquisition at CMS NADAC, 12/2025, plus a contracted dispensing fee. Ozempic WAC and commercial rebate, Oregon PDAB 2023/24. Legacy comparator: typical spread contract.
That was our example. Bring yours and we will open it the same way.
Do not take our word. Drive it yourself.
Annual savings on this drug
Semaglutide (GLP‑1) · 250 lives · per year
Per fill saved
$484.00
Fills per month
10
Saved per month
$4,840.00
Built to do prior authorization in seconds. Days at a legacy PBM.
14.0s
Approved
- 0.0sSubmitted
- 14.0sApproved
The incumbents made you wait because waiting was cheaper for them.
The rule: the AI never denies. It approves the clean cases and routes everything else to a licensed clinician. A faster yes is never an automated no. A pharmacist owns the criteria and signs anything off-pathway, and the exact criteria are logged on every decision.
Illustrative target for the clean path, not a measured median.
Switching is the part you fear. So we made it easy.
- 01
Disruption analysis first
Before anything moves, we model every member's current fills against the new plan. Nothing is a surprise on day one.
- 02
Same pharmacies
No network change. Every member keeps the counter they already use, with the same card in their wallet.
- 03
We do the paperwork
Eligibility files, ID cards, and member comms, with continuity on open prior auths, specialty, and GLP-1. Your team approves each step.
- 04
A human at go-live
Named, on the phone, the day the switch goes live. Not a ticket queue.
A benefit you can defend to your board.
Pay the pharmacy’s real cost, not a hidden markup, without changing networks. Every fill is itemized on its own line, with no quarterly mystery. Members keep the same pharmacies, the transition is modeled before anything moves, and a named human is on the phone at go-live.
On a level-funded plan? See how pharmacy benefits work in a level-funded plan.
Recommend it without betting your name on a black box.
Every claim is auditable, so you put your name on a number your client can open and check. It is defensible under CAA fee disclosure: clients see exactly what they pay, and why, so you arrive ahead of the rules, not behind them. You keep your client and your contract. Compensation is disclosed and flat, paid from our margin, and we never go direct to your book.
Questions a fiduciary asks.
What does 'pass-through' actually mean?
You pay exactly what the pharmacy was paid for the drug: no markup, no spread, 100% of rebates credited back. Our only charge is a separate flat per-employee-per-month administrative fee, disclosed in your contract. The drug cost is printed on every claim and reconciled to the cent.
What does 'pass-through' actually mean?
You pay exactly what the pharmacy was paid for the drug: no markup, no spread, 100% of rebates credited back. Our only charge is a separate flat per-employee-per-month administrative fee, disclosed in your contract. The drug cost is printed on every claim and reconciled to the cent.
What happens to manufacturer rebates?
100% of every rebate we capture is credited directly to your plan, line-itemed in the ledger as it arrives. We keep none as revenue. Rebate dollars depend on the manufacturer agreements in force and will differ from an incumbent's book. What does not differ is that we retain zero, and our contracts are visible to the plan sponsor.
Why should I trust a brand-new PBM?
You shouldn't. You should check us. Every claim is itemized down to the dollar: acquisition cost, dispensing fee, $0 spread, rebate credited back. We are not asking for the benefit of the doubt; we are removing the need for it. And the parts that have to be battle-tested are not new. Adjudication, the pharmacy network, and rebates sit on established rails the industry already relies on. What is new is the only thing that should be: a PBM that shows its work. The adjudication platform, pharmacy network, and rebate aggregator are named in your contract.
Will moving to Kanurra disrupt my members?
No network change is required. Members keep their pharmacies. We are not rebuilding the plumbing. Adjudication, network, and rebates sit on the same kind of proven infrastructure the incumbents use, with a flat-fee layer you can audit on top. Before anything moves we run a disruption analysis. Then we handle the eligibility files, ID cards, and member comms, with your team approving each step, and continuity on open prior authorizations, specialty, and GLP-1 therapies. Members should see the same counter, a clearer copay, and faster prior auth.
How fast can a group go live?
We set the go-live date with you against your plan year, and we will not promise one we cannot hit. Because the rails are proven rather than reinvented, go-live is not a science project. It is eligibility, formulary, and pharmacy-network setup on infrastructure that already works, with a named human on the phone at go-live and your team reviewing and approving every step.
How does the advisor or TPA get paid?
Your compensation is disclosed and flat, paid out of our margin, never carved from spread or a rebate the employer cannot see. You keep your client relationship and your master contract, and we do not go direct to a partner's book. The same fee disclosure that protects the employer protects you: it puts you ahead of the CAA and DOL transparency rules instead of exposed by them.
Who is clinically accountable?
By rule, a licensed pharmacist owns the formulary and signs every off-pathway prior-authorization decision, with the exact criteria applied logged on each claim. The AI is never allowed to deny: it approves the clean cases and escalates everything else to a clinician. Your clinical contacts are named in your contract.
How does Kanurra make money?
Only the flat per-employee-per-month administrative fee. Not spread, not rebate retention, not formulary placement, not pharmacy steering. That is the entire point.
See the real cost.
Then never go back.
Thirty minutes with your own claims, at no cost. We show you the money that never reached a pharmacy or your plan, line by line.